Status:
COMPLETED
TachoSil Versus Standard Surgical Treatment for Air Leakage in Pulmonary Lobectomy (TC-021-IM)
Lead Sponsor:
Nycomed
Conditions:
Pulmonary Diseases
Intraoperative Complications
Eligibility:
All Genders
18-90 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to compare the sealing efficacy and safety of TachoSil® (hereafter referred to as TachoSil) versus standard surgical treatment as the secondary management of intra-operati...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Subjects with a diagnosis of lung malignancy with or without metastases may be included in the trial if the entry criteria apply.
Exclusion
Key Trial Info
Start Date :
February 1 2006
Trial Type :
INTERVENTIONAL
End Date :
October 1 2007
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00293514
Start Date
February 1 2006
End Date
October 1 2007
Last Update
May 7 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nycomed
Roskilde, Denmark, 4000